Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point

In Depth

On Air

Archive
Feedback
Low Graphics
Help

Saturday, October 23, 1999 Published at 01:01 GMT 02:01 UK


Health

Key Alzheimer's protein found

Alzheimer's causes changes in the structure of the brain

Researchers have found a protein essential to the development of Alzheimer's disease.

They believe the discovery could pave the way for the development of drugs to treat the degenerative brain disease that are similar to those that have helped to combat the Aids virus.

The researchers, from California-based Amgen Inc and Harvard Medical School, say the protein, called BACE, stimulates other brain proteins to adopt a form that makes them damaging to the brain and causes Alzheimer's.

The disease starts with memory loss and progresses to profound dementia and death. There is no cure at present, although some drugs can slow the progression of the disease.

Alzheimer's patients have clots in their brains known as amyloid plaques and tangles of nerve cells.

A peptide, or protein fragment, known as amyloid beta peptide is believed to be key to the development of these plaques.

Critical role in the disease

Dr Martin Citron of Amgen, who led the research, said: "There has been overwhelming evidence over the last six years or so that the beta peptide that forms amyloid plaques plays an early and critical role in the disease."

This peptide is cut, or cleaved, off a larger protein known as amyloid precursor protein.

It was known that two special slicing proteins, known as proteases, did this. But no one could find them.

Now Dr Citron's team believe that they have identified BACE as one of these elusive proteases.

The researchers are now searching for a compound - a protease inhibitor - that can stop BACE from slicing up the amyloid precursor protein.

Protease inhibitors have been successfully used to keep HIV infection at manageable levels in thousands of patients.

But unlike the HIV protease inhibitors, one designed to work against Alzheimer's might work on its own.

"HIV is an infectious agent and it mutates at a very rapid pace whereas this one is not an infectious agent," Dr Citron said.

"There is a possibility that a protease inhibitor alone could do it. But only clinical trials could show that."

Dr Richard Harvey, director of research at the Alzheimer's Disease Society, said: "This research gives us a clue about new lines of investigation that could be followed potentially to develop new forms of treatment."

However, Dr Harvey warned that much more work was needed before any drugs could be developed.

He also stressed that preventing the formation of plaques in the brain would not necessarily prevent Alzheimer's as nobody was sure about the relationship between the plaques and the nerve tangles.





Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©


Health Contents

Background Briefings
Medical notes

Relevant Stories

06 Sep 99 | Medical notes
Alzheimer's disease

31 Aug 99 | Health
Whiplash 'could cause Alzheimer's'

04 Aug 99 | Health
Immune system 'worsens Alzheimer's'

21 May 99 | Health
Art therapy for Alzheimer's

05 Mar 99 | Health
Alzheimer's drug success

16 Feb 99 | Health
Drive to beat Alzheimer's Disease





Internet Links


Alzheimer's Disease Society

Alzheimers.com

Amgen


The BBC is not responsible for the content of external internet sites.




In this section

Disability in depth

Spotlight: Bristol inquiry

Antibiotics: A fading wonder

Mental health: An overview

Alternative medicine: A growth industry

The meningitis files

Long-term care: A special report

Aids up close

From cradle to grave

NHS reforms: A guide

NHS Performance 1999

From Special Report
NHS in crisis: Special report

British Medical Association conference '99

Royal College of Nursing conference '99